Clinical Trial Update: Long Term Effects of Raloxifene Treatment on Bone Quality [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the long-term effects of raloxifene on bone quality in postmenopausal osteoporosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Evista (raloxifene)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Post-Menopausal | Phase 4 | Status: COMPLETED